Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    Occipital Neuralgia
Show Display Options
RSS Create an RSS feed from your search for:
Occipital Neuralgia
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study Evaluating the Treatment of Occipital Neuralgia
Condition: Occipital Neuralgia
Intervention: Device: Device: Cryo-Touch III Study treatment at Day 0.
2 Completed
Has Results
Pulsed Radiofrequency vs. Steroid Injections for Occipital Neuralgia
Condition: Occipital Neuralgia
Interventions: Procedure: Pulsed radiofrequency;   Drug: Corticosteroid injection;   Drug: Local anethestic injection
3 Completed Greater Occipital Nerve Injection Study
Conditions: Occipital Neuralgia;   Cervicogenic Headache
Intervention: Procedure: GON injection at C2 location
4 Recruiting A Comparison of Dexamethasone and Triamcinolone for Ultrasound-guided Occipital C2 Nerve Blocks
Condition: Headache
Interventions: Drug: Triamcinolone;   Drug: Dexamethasone;   Drug: Normal Saline;   Drug: Bupivacaine
5 Recruiting Two US-guided Techniques for Greater Occipital Nerve Blocks
Condition: Primary Headache
Intervention: Procedure: US-guided Greater Occipital Nerve Injection
6 Not yet recruiting A Prospective Controlled Treatment Trial for Post-Traumatic Headaches
Condition: Post-Traumatic Headaches
Interventions: Procedure: Occipital Nerve Block (ONB);   Procedure: Cervical Medial Branch Block (CMBB)
7 Not yet recruiting Postoperative Analgesia in Patients With Microvascular Decompression
Condition: Trigeminal Neuralgia
Interventions: Drug: Ketamine;   Other: scalp nerve block;   Drug: ondansetron;   Drug: Sufentanil

Study has passed its completion date and status has not been verified in more than two years.